Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 亿帆医药股份有限公司是一家从事医药生产与开发的上市公司.主导产品为泛酸系列产品、用于治疗中风、肾结石、白内障、降血脂等方面的药品,以及骨青春片、降脂片等具有特色的保健食品.自2003年以来,公司已成为世界第一大生产D-泛酸钙产品生产厂商,同时也是国内唯一具备D-泛醇产品生产能力的企业。 | ||||||||||||||||||||||||
Main Business | 从事医药产品、原料药和高分子材料的研发、生产、销售及药品推广服务。 | ||||||||||||||||||||||||
Legal Representative | 程先锋 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 冯德崎 | ||||||||||||||||||||||||
Solicitors | 北京国枫律师事务所 | ||||||||||||||||||||||||
Auditors | 立信会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0551-62672019;0551-62672019 | ||||||||||||||||||||||||
Fax No | 0551-66100530;0551-66100530 | ||||||||||||||||||||||||
Website | www.yifanyy.com | ||||||||||||||||||||||||
xz@yifanyy.com;lilei@yifanyy.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 13/07/2004 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ -0.450 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 6.750 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 9.559B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |